apomorphine has been researched along with ym 09151-2 in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, M; Koshikawa, N; Maruyama, Y; Mori, E; Yatsushige, N | 1 |
| Arnt, J; Hyttel, J | 1 |
| Fitten, J; Gordon, LI; Kodama, CK; Menon, MK | 1 |
| Walters, JR; Weick, BG | 1 |
| Jenks, BG; Tonon, MC; Vaudry, H; Verburg-Van Kemenade, BM | 1 |
| Maeno, H; Nishikori, K; Noshiro, O; Usuda, S | 1 |
| Isa, Y; Kuribara, H; Morita, T; Sato, T; Uchihashi, Y | 1 |
| Dall'Olio, R; Gandolfi, O | 1 |
| Kikuchi de Beltrán, K; Kobayashi, M; Koshikawa, N; Miwa, Y | 1 |
| Kamijo, N; Nagao, T; Ono, H | 1 |
| Kikuchi de Beltrán, K; Kobayashi, M; Koshikawa, N; Miwa, Y; Stephenson, JD | 1 |
| Matsumoto, A; Pauwels, PJ; Wurch, T | 1 |
| Finlay, HE; Martin, LP; Stellar, JR; Waszczak, BL; Zahr, N | 1 |
| Kang, UJ; Kim, YS; Lee, EA; Lee, WY | 1 |
| Martin, LP; Waszczak, BL; Zahr, NM | 1 |
| Assié, MB; Consul-Denjean, N; Dominguez, H; Newman-Tancredi, A | 1 |
| Assié, MB; Auclair, A; Bardin, L; Consul-Denjean, N; Depoortère, R; Newman-Tancredi, A; Sautel, F | 1 |
17 other study(ies) available for apomorphine and ym 09151-2
| Article | Year |
|---|---|
Role of dopamine D-1 and D-2 receptors in the ventral striatum in the turning behaviour of rats.
Topics: Animals; Apomorphine; Benzamides; Benzazepines; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Flupenthixol; Male; Methamphetamine; Microinjections; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride | 1990 |
Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzamides; Drug Combinations; Male; Motor Activity; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Stereotyped Behavior | 1990 |
Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Anti-Anxiety Agents; Apomorphine; Benzamides; Benzazepines; Dopamine; Dopamine Antagonists; Ergolines; Haloperidol; Hypothermia; Male; Mice; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1988 |
Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Apomorphine; Benzamides; Benzazepines; Dopamine; Dopamine Antagonists; Drug Interactions; Ergolines; Hydroxydopamines; Male; Oxidopamine; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra; Time Factors | 1987 |
Characteristics of receptors for dopamine in the pars intermedia of the amphibian Xenopus laevis.
Topics: Animals; Apomorphine; Benzamides; Domperidone; Dopamine; Drug Interactions; Ergolines; Haloperidol; Melanocyte-Stimulating Hormones; Pituitary Gland, Anterior; Quinpirole; Receptors, Dopamine; Sulpiride; Xenopus laevis | 1986 |
Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Chlorpropamide; Dogs; Drug Evaluation, Preclinical; Female; Haloperidol; Humans; Hypothermia; Male; Methamphetamine; Mice; Mice, Inbred ICR; Receptors, Dopamine; Stereotyped Behavior; Sulpiride; Vomiting | 1981 |
The disruptive effects of ketamine on passive avoidance learning in mice: involvement of dopaminergic mechanism.
Topics: Animals; Apomorphine; Avoidance Learning; Benzamides; Benzazepines; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electroshock; Ketamine; Male; Memory; Mice; Mice, Inbred Strains; Receptors, Dopamine D1; Synaptic Transmission; Vocalization, Animal | 1994 |
The NMDA positive modulator D-cycloserine potentiates the neuroleptic activity of D1 and D2 dopamine receptor blockers in the rat.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Benzazepines; Cycloserine; Dizocilpine Maleate; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; N-Methylaspartate; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Stereotyped Behavior | 1993 |
Dorsal striatal mechanisms involved in the dopamine D2 receptor-mediated potentiation of apomorphine-induced jaw movements.
Topics: Animals; Apomorphine; Benzamides; Benzazepines; Corpus Striatum; Dopamine Agents; Dopamine D2 Receptor Antagonists; Drug Synergism; Ergolines; Jaw; Male; Motor Activity; N-Methylscopolamine; Parasympatholytics; Pyrrolidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Scopolamine Derivatives; Sulpiride | 1994 |
Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzamides; Bromocriptine; Decerebrate State; Depression, Chemical; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Reflex, Monosynaptic; Sulpiride; Synaptic Transmission | 1993 |
Further evidence for a functional dorsal-ventral division of the rat striatum: GABAergic involvement in oral movements.
Topics: Animals; Apomorphine; Behavior, Animal; Benzamides; Benzazepines; Carbachol; Corpus Striatum; Dopamine; Flunitrazepam; gamma-Aminobutyric Acid; Jaw; Male; Muscimol; N-Methylscopolamine; Picrotoxin; Pilocarpine; Rats; Rats, Sprague-Dawley; Scopolamine Derivatives | 1993 |
Agonist-independent and -dependent oligomerization of dopamine D(2) receptors by fusion to fluorescent proteins.
Topics: Animals; Apomorphine; Bacterial Proteins; Benzamides; CHO Cells; COS Cells; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Guanosine 5'-O-(3-Thiotriphosphate); Luminescent Proteins; Protein Structure, Quaternary; Receptors, Dopamine D2; Recombinant Fusion Proteins; Transfection | 2001 |
Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
Topics: Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Benzamides; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Electrophysiology; Extracellular Space; Male; Membrane Potentials; Microinjections; Quinpirole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra | 2002 |
The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations.
Topics: Animals; Antiparkinson Agents; Apomorphine; Autoradiography; Benzamides; Disease Models, Animal; Dopamine Agonists; Dyskinesias; Female; Forelimb; Immunohistochemistry; Levodopa; Medial Forebrain Bundle; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Presynaptic | 2003 |
Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
Topics: Action Potentials; Animals; Apomorphine; Basal Ganglia; Benzamides; Benzazepines; Brain Diseases; Brain Mapping; Cell Count; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Male; Neurons; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus | 2004 |
In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Binding, Competitive; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Mice; Neostriatum; Olfactory Bulb; Receptors, Dopamine D2; Serotonin Receptor Agonists | 2006 |
F15063, a potential antipsychotic with dopamine D(2)/D(3) antagonist, 5-HT(1A) agonist and D(4) partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Benzofurans; Benzylamines; Cyclopentanes; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Mice; Receptors, Dopamine D3; Receptors, Dopamine D4; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists | 2007 |